| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 1,085 | 1,152 | 1,150 | 1,024 | 1,106 | 1,176 | 1,257 | 1,630 | 1,164 | 1,229 | 1,258 | 1,175 | 1,108 | 1,081 | 1,156 | 1,164 | 1,528 | 1,170 | 1,277 | 1,178 | 1,133 | 614 | 1,029 | 1,205 | 1,278 | 1,733 | 1,475 | 1,487 | 1,391 | 1,519 | 1,682 | 1,586 | 1,669 | 1,667 | 1,788 | 1,699 | 1,803 | 1,873 | 2,006 | 1,975 | 2,032 | 2,198 |
| Expenses | 1,022 | 986 | 1,087 | 1,066 | 1,091 | 1,059 | 1,097 | 1,023 | 1,045 | 1,071 | 1,138 | 1,069 | 1,907 | 1,034 | 1,172 | 1,193 | 1,069 | 996 | 1,028 | 1,012 | 987 | 709 | 875 | 987 | 1,055 | 1,135 | 1,178 | 1,180 | 1,157 | 1,237 | 1,304 | 1,283 | 1,372 | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,613 | 1,553 | 1,625 | 1,676 |
| EBITDA | 62 | 166 | 62 | -42 | 15 | 118 | 160 | 607 | 118 | 158 | 120 | 106 | -799 | 47 | -16 | -29 | 459 | 174 | 250 | 166 | 146 | -96 | 155 | 218 | 223 | 598 | 297 | 307 | 234 | 282 | 378 | 302 | 297 | 282 | 349 | 303 | 398 | 356 | 393 | 422 | 406 | 522 |
| Operating Profit % | 3 % | 4 % | -2 % | -5 % | -2 % | 6 % | 8 % | 10 % | 7 % | 7 % | 5 % | 5 % | -76 % | 1 % | -3 % | -8 % | 10 % | 13 % | 15 % | 13 % | 11 % | -17 % | 12 % | 16 % | 16 % | 20 % | 19 % | 20 % | 16 % | 17 % | 19 % | 18 % | 16 % | 16 % | 19 % | 17 % | 21 % | 18 % | 19 % | 19 % | 19 % | 23 % |
| Depreciation | 61 | 53 | 0 | 0 | 72 | 48 | 52 | 60 | 63 | 59 | 61 | 59 | 60 | 57 | 56 | 60 | 60 | 71 | 71 | 70 | 80 | 72 | 74 | 73 | 72 | 73 | 75 | 76 | 77 | 74 | 77 | 83 | 82 | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 102 |
| Interest | 37 | 34 | 30 | 32 | 38 | 42 | 46 | 75 | 67 | 64 | 66 | 63 | 64 | 76 | 85 | 111 | 65 | 51 | 49 | 48 | 57 | 41 | 42 | 42 | 41 | 38 | 40 | 38 | 30 | 31 | 33 | 33 | 32 | 32 | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 |
| Profit Before Tax | -22 | 88 | 44 | -58 | -96 | 28 | 62 | 472 | -11 | 35 | -7 | -17 | -924 | -87 | -157 | -201 | 334 | 52 | 130 | 48 | 9 | -208 | 38 | 103 | 110 | 486 | 182 | 193 | 126 | 176 | 268 | 186 | 183 | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 | 351 |
| Tax | -10 | -9 | -17 | -29 | -8 | 3 | 24 | 19 | 26 | 12 | 17 | 3 | -9 | -34 | -15 | -20 | 183 | -26 | 6 | 118 | 50 | -20 | 23 | 49 | 48 | 56 | 51 | 51 | 39 | 42 | 50 | 44 | 45 | 47 | 49 | 49 | 68 | 56 | 68 | 25 | 49 | 84 |
| Net Profit | -12 | 97 | 61 | -29 | -88 | 25 | 38 | 453 | -38 | 23 | -24 | -19 | -914 | -53 | -142 | -180 | 151 | 78 | 124 | -69 | -41 | -188 | 16 | 54 | 62 | 431 | 131 | 142 | 87 | 134 | 218 | 142 | 138 | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 | 267 |
| EPS in ₹ | -0.38 | 2.01 | 1.19 | -0.65 | -1.91 | 0.35 | 0.68 | 9.49 | -0.79 | 0.10 | -0.88 | -0.71 | -17.97 | -1.36 | -3.21 | -3.06 | 1.80 | 0.90 | 1.47 | -1.01 | -0.59 | -2.37 | -0.05 | 0.40 | 0.57 | 3.49 | 1.42 | 1.55 | 0.90 | 1.62 | 2.71 | 1.72 | 1.76 | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 |
Fortis Healthcare
Fortis Healthcare
956.60
+26.85
(2.89%)
Market Cap
72,219.30 Cr
EPS
10.26
PE Ratio
78.19
Dividend Yield
0.10 %
Industry
Healthcare Services52 Week High
971.00
52 Week Low
537.40
PB Ratio
8.10
Debt to Equity
0.22
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from13 analysts
Company News
View All News
Fortis Healthcare has taken control of a 200-bed hospital in Greater Noida through a long-term lease arrangement. This expansion increases the company's total bed capacity in the Delhi-NCR region to approximately 2,000 beds. The move is aimed at providing wider healthcare access and enhancing collaborations in the region.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,162.00 | #1 1,12,963.50 | 94.23 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 37.20 | |
7,736.00 | 1,11,231.80 | 70.63 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 57.49 | |
956.60 | #3 72,219.30 | #6 78.19 | #2 7,849.70 | #8 13.25 | #3 809 | #1 53.33 | 69.00 | |
1,427.20 | 38,332.80 | 67.27 | 3,771.40 | 21.40 | 481 | 49.58 | 63.69 | |
1,809.20 | 36,973.00 | #1 46.79 | 5,575.00 | 12.29 | 790 | -2.38 | 46.80 | |
620.15 | 32,131.30 | 89.86 | 4,286.70 | 15.12 | 337 | -98.18 | 57.06 | |
737.60 | 29,514.20 | 79.82 | 3,067.00 | 21.98 | 415 | -10.71 | 49.95 | |
1,509.90 | 15,333.30 | 59.53 | 1,566.90 | 17.46 | 244 | 35.52 | 46.33 | |
694.25 | 9,678.90 | 260.92 | 2,218.14 | 12.97 | 28 | -55.88 | 70.38 | |
1,438.20 | 9,429.70 | 48.95 | 1,290.20 | 17.77 | 194 | -1.57 | 52.16 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
13.25 %
Net Income Growth
25.45 %
Cash Flow Change
29.44 %
ROE
17.11 %
ROCE
0.92 %
EBITDA Margin (Avg.)
11.89 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 | 13,692 |
| Fixed Assets | 4,218 | 3,776 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 | 10,424 |
| Current Assets | 1,636 | 1,434 | 1,775 | 1,282 | 1,667 | 941 | 1,037 | 1,133 | 1,406 | 1,421 | 1,471 |
| Capital Work in Progress | 228 | 201 | 268 | 226 | 450 | 204 | 165 | 194 | 228 | 542 | 407 |
| Investments | 616 | 1,449 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 |
| Other Assets | 2,554 | 1,807 | 2,152 | 1,672 | 2,755 | 2,167 | 2,005 | 2,172 | 2,569 | 2,643 | 2,692 |
| Total Liabilities | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 | 13,692 |
| Current Liabilities | 1,602 | 1,476 | 1,927 | 2,134 | 3,591 | 2,579 | 1,233 | 1,269 | 1,426 | 3,170 | 1,607 |
| Non Current Liabilities | 1,813 | 1,616 | 1,480 | 1,171 | 1,248 | 1,563 | 3,204 | 3,607 | 2,907 | 1,563 | 2,915 |
| Total Equity | 4,201 | 4,140 | 6,311 | 5,317 | 7,113 | 7,206 | 6,718 | 7,008 | 8,100 | 8,556 | 9,169 |
| Reserve & Surplus | 3,585 | 3,534 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 | 8,162 |
| Share Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 | 755 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -66 | -38 | 225 | -513 | 799 | -627 | 212 | -153 | -22 | 125 | -70 |
| Investing Activities | 213 | 122 | -1,001 | -333 | -3,279 | 64 | -131 | -501 | -373 | -889 | -780 |
| Operating Activities | 24 | 195 | 967 | 493 | -179 | 172 | 486 | 865 | 822 | 1,100 | 1,424 |
| Financing Activities | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -87 | -714 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 26.32 % | 0.00 % | 23.24 % | 23.31 % | 25.26 % | 26.77 % | 27.40 % | 27.17 % |
| DIIs | 13.44 % | 15.20 % | 15.66 % | 15.50 % | 16.72 % | 17.44 % | 19.94 % | 20.38 % | 20.70 % | 22.16 % | 26.55 % | 29.35 % | 31.15 % | 32.31 % | 30.73 % | 30.05 % | 29.46 % | 29.79 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.96 % | 15.16 % | 15.98 % | 14.89 % | 13.96 % | 13.58 % | 12.92 % | 12.39 % | 12.05 % | 11.80 % | 11.13 % | 11.04 % | 10.82 % | 10.47 % | 10.36 % | 10.21 % | 10.22 % | 10.17 % |
| Others | 41.43 % | 38.47 % | 37.20 % | 38.44 % | 38.15 % | 37.82 % | 35.98 % | 36.06 % | 36.08 % | 34.86 % | 4.83 % | 28.44 % | 3.63 % | 2.75 % | 2.48 % | 1.81 % | 1.75 % | 1.70 % |
| No of Share Holders | 0 | 1,09,889 | 1,44,634 | 1,66,743 | 1,54,572 | 1,56,881 | 1,60,762 | 1,58,455 | 1,37,894 | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.14 | 0.1 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Jul 2023 |  Dividend | ₹ 1.00 /share | 20 Jul 2023 | 289.05 | 328.75 |
| 24 Jul 2024 | Dividend | ₹ 1.00 /share | 24 Jul 2024 | 469.50 | 487.45 |
| 02 Aug 2024 |  Annual General Meeting | NA | 02 Aug 2024 | 471.55 | 505.05 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 601.65 | 623.10 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 581.00 | 651.05 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 682.75 | 685.85 |
| 25 Jul 2025 | Dividend | ₹ 1.00 /share | 25 Jul 2025 | 685.85 | 846.55 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 850.05 | 867.90 |
| 11 Aug 2025 | Annual General Meeting | NA | 11 Aug 2025 | 773.45 | 897.45 |
Announcements
Announcement under Regulation 30 (LODR)-Credit Rating
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
2 days agoExecution Of Sub-Lease Agreement With R.R. Lifesciences Pvt Ltd2 days ago
2 days agoEffective Date Of Scheme Of Arrangement2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement2 days ago
2 days agoRegulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
(Listing Regulations) - Intimation Of Revision In ESG Rating Assigned By CRISIL9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 20, 2025
Aug 20, 2025Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesAug 20, 2025
Aug 20, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 11, 2025
Aug 11, 2025Appointment Of M/S Neelam Gupta & Associates Company Secretaries (Firm Registration No. S2006DE086800) Who Is A Peer Reviewed Company Secretary In Practice As Secretarial Auditors Of The Company For A Term Of 5 (Five) Consecutive Years Commencing From FinAug 11, 2025
Aug 11, 2025Summary Of Proceedings Of The 29Th Annual General Meeting Of The Company Held On Monday August 11 2025 At 14:00 Hours (IST) Through Video Conferencing/ Other Audio Visual Means (VC/OAVM)
Aug 11, 2025
Aug 11, 2025Summary Of The Proceedings Of The 29Th Annual General Meeting Of The Company Held On Monday August 11 2025 At 14:00 Hours (IST) Through Video Conferencing/ Other Audio Visual Means (VC/OAVM)Aug 11, 2025
Aug 11, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Aug 06, 2025Compliances-Reg. 54 - Asset Cover details Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2025
Aug 06, 2025Outcome Of The Board Meeting Under Regulation 30 33 Regulation 51(2) And 52 Of Securities Andexchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015Aug 06, 2025
Aug 06, 2025Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJul 31, 2025
Jul 31, 2025Approval Of Scheme Of Arrangement By HonBle NCLTJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Jul 31, 2025Board Meeting Intimation for Prior Intimation Of Board Meeting Under Regulation 29 And 50 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 30, 2025
Jul 30, 2025Update On Consummation Of Shrimann Superspecialty Hospital TransactionJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Jul 23, 2025Intimation On Operation And Maintenance Services Agreement With Gleneagles Healthcare India Private LimitedJul 23, 2025
Jul 23, 2025Update On SRL TrademarksJul 20, 2025
Jul 20, 2025Intimation On Tax Deduction At Source (TDS)/Withholding Tax On DividendJul 17, 2025
Jul 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 15, 2025
Jul 15, 2025Letters Contain The Weblink To Access The Annual Report Of Financial Year 2024-25Jul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 14, 2025
Jul 14, 2025Record Date Fixed For Dividend PaymentJul 14, 2025
Jul 14, 2025Please Find Enclosed The Intimation Of Date Of Closure Of Register Of Members & Share Transfer BookJul 14, 2025
Jul 14, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 14, 2025
Jul 14, 2025Regulation 53 (1) Annual Report.Jul 14, 2025
Jul 14, 2025Reg. 34 (1) Annual Report.Jul 14, 2025
Jul 14, 2025Intimation Of Notice Of 29Th AGM Of Fortis Healthcare Limited To Be Held On August 11 2025Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Jul 11, 2025Disclosure On Completion Of Term Of Independent DirectorJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Technical Indicators
RSI(14)
Neutral 69.00
ATR(14)
Volatile 20.69
STOCH(9,6)
Neutral 30.49
STOCH RSI(14)
Neutral 27.56
MACD(12,26)
Bearish -3.67
ADX(14)
Strong Trend 46.29
UO(9)
Bearish 51.51
ROC(12)
Uptrend And Accelerating 2.64
WillR(14)
Neutral -21.62
Mutual Fund Holdings
Tata Large & Mid Cap Fund Direct Plan-Growth 
Kotak Multi Asset Allocation Fund Direct - Growth 
Edelweiss Balanced Advantage Fund Direct-Growth 
HDFC Mid Cap Fund Direct-Growth 
Mirae Asset Midcap Fund Direct - Growth 
Axis Large & Mid Cap Fund Direct-Growth 
ICICI Prudential Equity Arbitrage Direct-Growth 
Mahindra Manulife Multi Cap Fund Direct - Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth 
TRUSTMF Flexi Cap Fund Direct - Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
Bandhan Midcap Fund Direct-Growth 
SBI Arbitrage Opportunities Fund Direct-Growth 
Invesco India Arbitrage Fund Direct-Growth 
Aditya Birla Sun Life Equity Hybrid '95 Fund Direct-Growth 
WhiteOak Capital Large & Mid Cap Fund Direct - Growth 
DSP Arbitrage Fund Direct - Growth About Fortis Healthcare
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years,
-5 days)
Chairperson NameLeo Puri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
